---
search:
  boost: 3
---

# Nasal Preparations

This is a subcategory of Respiratory Agents.

## Decision Tree

- [Respiratory - Nasal Preparations - NP Criteria - Azelastine/Fluticasone Spray, Beconase AQ, Mometason, Omnaris, Qnasl, Xhance, Zetonna](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNjcxMjRWQTRKTzNXNkJEMUdaVjhBNDJMQyQlQCN0PWcu){ :target="_blank" rel="noopener"}

## Formulary

### Preferred

| Preferred                        | Generic Name                              | Quantity | Time (Days) |
|:---------------------------------|:------------------------------------------|:--------:|:-----------:|
| Azelastine                       |                                           |          |             |
| Flunisolide                      |                                           |          |             |
| Fluticasone (Generic of Flonase) |                                           |          |             |
| Ipratropium <sup>QL</sup>        | Ipratropium Bromide Inhalation Soln 0.02% |   1020   |     102     |
| Olopatadine                      |                                           |          |             |

### Non-Preferred

| Non-Preferred                  | Generic Name | Quantity | Time (Days) |
|:-------------------------------|:-------------|:--------:|:-----------:|
| Azelastine / Fluticasone Spray |              |          |             |
| Beconase AQ                    |              |          |             |
| Budesonide                     |              |          |             |
| Mometasone                     |              |          |             |
| Omnaris                        |              |          |             |
| Qnasl                          |              |          |             |
| Ryaltris                       |              |          |             |
| Xhance                         |              |          |             |
| Zetonna                        |              |          |             |

## Authorizations

**Length of Authorizations**: 365 days

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Non-Preferred

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response to at least **30 days** with at least **two preferred** drugs in the same class, if available
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

## Links

[Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)](https://mygainwell-my.sharepoint.com.mcas.ms/:w:/r/personal/rachel_carpenter_gainwelltechnologies_com/_layouts/15/Doc.aspx?sourcedoc=%7BCD777F63-7F18-4713-8D6A-B043BEE631F5%7D&file=Denial%20Language%20Updated%2009112023.docx&action=embedview&mobileredirect=true&wdStartOn=98&cid=f4472ece-6d4f-4694-b0c5-c150a2f53fea){:target="_blank" rel="noopener"} 

[Criteria](https://medicaid.ohio.gov/static/PHM/drug-coverage/20231001+UPDL+Criteria+_v2.FINAL.pdf#page=100){ :target="_blank" rel="noopener"}

[Preferred Drug List](https://medicaid.ohio.gov/static/PHM/drug-coverage/20231001_UPDL_V2.FINAL.hyperlinks_added.pdf#page=32){ :target="_blank" rel="noopener"}

[Quantity Limit List](https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/Quantity%20Limits.pdf){ :target="_blank" rel="noopener"}
